1
|
Calvo-Martín G, Plano D, Martínez-Sáez N, Aydillo C, Moreno E, Espuelas S, Sanmartín C. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments. Pharmaceuticals (Basel) 2022; 15:ph15121465. [PMID: 36558915 PMCID: PMC9780886 DOI: 10.3390/ph15121465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 11/20/2022] [Accepted: 11/22/2022] [Indexed: 11/29/2022] Open
Abstract
The norbornene scaffold has arisen as a promising structure in medicinal chemistry due to its possible therapeutic application in cancer treatment. The development of norbornene-based derivatives as potential chemotherapeutic agents is attracting significant attention. Here, we report an unprecedented review on the recent advances of investigations into the antitumoral efficacy of different compounds, including the abovementioned bicyclic scaffold in their structure, in combination with chemotherapeutic agents or forming metal complexes. The impact that structural modifications to these bicyclic compounds have on the antitumoral properties and the mechanisms by which these norbornene derivatives act are discussed in this review. In addition, the use of norbornene, and its related compounds, encapsulation in nanosystems for its use in cancer therapies is here detailed.
Collapse
Affiliation(s)
- Gorka Calvo-Martín
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
| | - Daniel Plano
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Correspondence: (D.P.); (C.A.); Tel.: +34-948425600 (ext. 806358) (D.P.); +34-948425600 (ext. 803183) (C.A.)
| | - Nuria Martínez-Sáez
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
| | - Carlos Aydillo
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Correspondence: (D.P.); (C.A.); Tel.: +34-948425600 (ext. 806358) (D.P.); +34-948425600 (ext. 803183) (C.A.)
| | - Esther Moreno
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
| | - Socorro Espuelas
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
| | - Carmen Sanmartín
- Departamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, E-31008 Pamplona, Spain
- Instituto de Salud Tropical, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain
| |
Collapse
|
2
|
Mitasev B, Yang J, Gusovsky F, Girish D, Khile AS, Balla VS, Vikram V, Vaddi A, Bathula S, Sugandham SR, Terli C, Kalla V, Rayaprolu PK, Talabhakthula RK, Gotoda M, Melillo B, Schreiber SL, Fang FG. Crystallization-Based Synthetic Route to Antimalarial Agent BRD5018: Diazocene Ring Formation via a Staudinger-aza-Wittig Reaction on an Azetidine-Ribose Template. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.1c00225] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Branko Mitasev
- G2D2 Eisai Inc., 35 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Jiong Yang
- G2D2 Eisai Inc., 35 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Fabian Gusovsky
- G2D2 Eisai Inc., 35 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| | - Dixit Girish
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Anil Shahaji Khile
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Venkata Sasidhar Balla
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Venugopalarao Vikram
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Anand Vaddi
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Srikanth Bathula
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Srinivasa Rao Sugandham
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Chiranjeevi Terli
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Vijay Kalla
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Pavan Kumar Rayaprolu
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Ravi Kumar Talabhakthula
- Eisai Pharmaceuticals India Pvt. Ltd., Ramky Pharma City, (SEZ), Plot Nos. 96, 97, 98, 124, &126, Parawada, Visakhapatnam, Andhra Pradesh 531019, India
| | - Masaharu Gotoda
- Analytical Research Japan, Pharmaceutical Science & Technology, Medicine Development Center, Eisai Co. Ltd., 5-1-3-Tokodai, Tsukuba-shi, Ibaraki 300-2635, Japan
| | - Bruno Melillo
- Chemical Biology and Therapeutics Science Program, Broad Institute of Harvard and MIT, 415 Main Street, Cambridge, Massachusetts 02142, United States
- Department of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States
| | - Stuart L. Schreiber
- Chemical Biology and Therapeutics Science Program, Broad Institute of Harvard and MIT, 415 Main Street, Cambridge, Massachusetts 02142, United States
- Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, United States
| | - Francis G. Fang
- G2D2 Eisai Inc., 35 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
| |
Collapse
|
3
|
Zeng Y, Guo Y, Zhang Y, Wang X, Jiang Y, Yang D. Rapid profiling of cantharidin analogs in Mylabris phalerata Pallas by ultra-performance liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry. Biomed Chromatogr 2020; 34:e4801. [PMID: 31999361 DOI: 10.1002/bmc.4801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2019] [Revised: 01/03/2020] [Accepted: 01/28/2020] [Indexed: 12/18/2022]
Abstract
We evaluated the protective effect and toxicity of extracts from Mylabris phalerata Pallas by measuring the activated partial thromboplastin time, prothrombin time, venous thrombosis and acute toxicity in rats. Results showed the petroleum ether and water fractions of M. phalerata inhibited thrombosis but hardly prolonged the activated partial thromboplastin time and prothrombin time in rats. The trichloromethane fraction had obvious toxicity with an LD50 of 0.2 g/kg in vivo, and contained many cantharidin analogs (CAs) by ultra-performance liquid chromatography-quadrupole ion trap-tandem mass spectrometry (UPLC-QTRAP-MS/MS). CAs are the major potential bioactivity constituent in M. phalerata. An effective and reliable UPLC-QTRAP-MS/MS method was successfully developed to separate and identify CAs. The fragmentation patterns of five purified compounds were applied to elucidate the structure of their analogs. Thirty-four CAs were characterized or tentatively identified, eight of which are proposed to be novel compounds (13-17, 20, 21, 23), and their fragmentation patterns were investigated for the first time. Most importantly, a rapid and reliable UPLC-MS method was developed to identify the CAs of M. phalerata. This method has contributed to the discovery of most of these unknown analogs or their metabolites in M. phalerata effectively and quickly, and does not rely on limited chemical structural diversity libraries.
Collapse
Affiliation(s)
- Yaobo Zeng
- Chongqing Academy of Chinese Materia Medica, People's Republic of China
| | - Yanlei Guo
- Chongqing Academy of Chinese Materia Medica, People's Republic of China
| | - Yi Zhang
- Chongqing Academy of Chinese Materia Medica, People's Republic of China
| | - Xianying Wang
- Chongqing Academy of Chinese Materia Medica, People's Republic of China
| | - Yao Jiang
- Chongqing Academy of Chinese Materia Medica, People's Republic of China
| | - Dajian Yang
- Chongqing Academy of Chinese Materia Medica, People's Republic of China.,Comprehensive Health Center of Chongqing Research Institute of Traditional Chinese Medicine, People's Republic of China
| |
Collapse
|
4
|
Akhtar R, Naqvi SAR, Zahoor AF, Saleem S. Nucleophilic ring opening reactions of aziridines. Mol Divers 2018; 22:447-501. [PMID: 29728870 DOI: 10.1007/s11030-018-9829-0] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2018] [Accepted: 04/23/2018] [Indexed: 12/29/2022]
Abstract
Aziridine ring opening reactions have gained tremendous importance in the synthesis of nitrogen containing biologically active molecules. During recent years, a great effort has been put forward by scientists toward unique bond construction methodologies via ring opening of aziridines. In this regard, a wide range of chiral metal- and organo-catalyzed desymmetrization reactions of aziridines have been reported with carbon, sulfur, oxygen, nitrogen, halogen, and other nucleophiles. In this review, an outline of methodologies adopted by a number of scientists during 2013-2017 for aziridine ring opening reactions as well as their synthetic applications is described.
Collapse
Affiliation(s)
- Rabia Akhtar
- Department of Chemistry, Government College University Faisalabad, Faisalabad, 38000, Pakistan
| | - Syed Ali Raza Naqvi
- Department of Chemistry, Government College University Faisalabad, Faisalabad, 38000, Pakistan
| | - Ameer Fawad Zahoor
- Department of Chemistry, Government College University Faisalabad, Faisalabad, 38000, Pakistan.
| | - Sameera Saleem
- Department of Chemistry, Government College University Faisalabad, Faisalabad, 38000, Pakistan
| |
Collapse
|